The MedTech Horizon: Exploring the Frontier of Cardiovascular Device Development in Heart Failure

Medical Device, Medical Device Innovations,
  • Thursday, March 14, 2024

In recent years, significant strides have been made in cardiovascular pharmacotherapy. Moving beyond the pillars of pharmacological heart failure treatment, a new frontier emerges. In this upcoming webinar, leading cardiovascular experts delve into the realm of cardiovascular devices, assessing their potential to redefine the trajectory of heart failure, ultimately aiming to keep individuals out of the hospital and on a stable plateau for extended periods.

Join the featured speakers as they showcase groundbreaking devices with transformative potential:

  • Neuromodulation in heart disease: Highlighting innovative applications, from baroreceptor activation therapy to cardiac pulmonary nerve stimulation
  • Interventions for heart failure: Showcasing devices for reverse remodeling, including electrical and physical remodeling devices, shunt devices and decongestion devices
  • Structural and valvular heart disease: Focusing on the prevalence of valvular heart disease and exploring catheter-based interventions for aortic, mitral and tricuspid valves — emphasizing the therapeutic potential in mitigating aortic and mitral regurgitation as well as addressing severe tricuspid regurgitation

This exploration of leading-edge cardiovascular devices aims to provide a holistic understanding of their potential impact on heart failure management, introducing a new era of personalized and effective cardiovascular care. Join this webinar as the featured speakers navigate the frontier of innovation in cardiovascular device development, striving to enhance patient outcomes and quality of life.


Dean J. Kereiakes, MD, Medpace

Dean J. Kereiakes, MD, FACC, MSCAI, Vice-President, Medical Department, Medpace

Dr. Dean J. Kereiakes is Chairman and Medical Director of The Christ Hospital Heart and Vascular Institute, Medical Director of The Christ Hospital Research Institute and Professor of Clinical Medicine at The Ohio State University. At Medpace, Dr. Kereiakes serves as Medical Department Vice-President, providing hands-on medical leadership to sponsors and internal study teams engaged in cardiovascular clinical research.

He received his medical degree and was valedictorian of his graduating class at the University of Cincinnati in Ohio with postgraduate internship and residency at the University of California in San Francisco, senior residency at Massachusetts General Hospital in Boston and chief residency at the University of California. He completed fellowships in adult cardiology at the University of California and in coronary angioplasty at the San Francisco Heart Institute and the Sequoia Hospital.

Dr. Kereiakes has been a national/international Principal Investigator in trials for FDA approval of more than 26 novel drugs and medical devices. He founded and was Medical Director of The Carl & Edyth Lindner Center for Research and Education at The Christ Hospital, one of the top clinical research sites in the United States. Dr. Kereiakes has performed multiple First in Human and First in the US use of novel medical devices.

Dr. Kereiakes has published over 1200 peer-reviewed journal articles, abstracts and book chapters. He previously was Section Editor for Circulation and is currently Deputy Editor for the Journal of the Society for Coronary Angiography and Intervention (JSCAI).

Message Presenter
Adam M. Lubert, Medpace

Adam M. Lubert, MD, Medical Department, Medpace

Dr. Adam M. Lubert is an academic Cardiologist with board certifications in internal medicine, pediatrics, pediatric cardiology and adult congenital heart disease. At Medpace, he provides hands-on medical leadership to sponsors and internal study teams engaged in cardiovascular clinical research. He completed an internal medicine and pediatrics combined residency at the University of Cincinnati and cardiology training at the University of Michigan.

He served as an Adult Congenital Cardiologist on faculty at The University of Cincinnati and Cincinnati Children’s Hospital from 2018 to 2023. During that time, he started a heart failure clinic specializing in caring for a subset of patients with congenital heart failure. He has authored over 40 peer-reviewed publications and numerous book chapters across a broad range of cardiovascular conditions.

Message Presenter
Aung Myat, Medpace

Aung Myat, MRCP, MD, FACC, FESC, Medical Department, Medpace

Dr. Aung Myat is a board-certified Interventional Cardiologist and Clinician Scientist. At Medpace, he provides hands-on medical leadership to sponsors and internal study teams engaged in cardiovascular clinical research. Dr. Myat has an established track record in clinical trial design, governance and execution, medical writing, retrospective and prospective large dataset analysis, education, training, mentorship and academic supervision.

He has over 20 years of medical experience working as a NHS Clinician and was, most recently, the leader of a multidisciplinary team delivering protocol-driven treatment in a Hospital Foundation Trust rated “Outstanding” by the Care Quality Commission.

Message Presenter

Who Should Attend?

This webinar will appeal to VPs, Directors, Managers and Department Heads working within:

  • Clinical affairs
  • Clinical research
  • Clinical pharmacology
  • Clinical outsourcing
  • Clinical operations
  • Regulatory affairs
  • Medical affairs

What You Will Learn

Attendees will gain insights into:

  • Emerging cardiovascular devices and their potential to redefine the trajectory of heart failure, including:
    • Neuromodulation in heart disease
    • Interventions for heart failure
    • Structural and valvular heart disease

Xtalks Partner


Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective.

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account